nonarteritic anterior ischemic optic neuropathy
Showing 1 - 4 of 4
Nonarteritic Anterior Ischemic Optic Neuropathy Trial in United States (RPh201 Cohort A, Placebo Cohort A, RPh201 Cohort B)
Terminated
- Nonarteritic Anterior Ischemic Optic Neuropathy
- RPh201 Cohort A
- +3 more
-
Palo Alto, California
- +14 more
Oct 8, 2020
NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Completed
- Nonarteritic Anterior Ischemic Optic Neuropathy
- PDE5 Inhibitors
-
Birmingham, Alabama
- +43 more
Sep 5, 2017
Nonarteritic Anterior Ischemic Optic Neuropathy Trial in Aurora (ranibizumab)
Completed
- Nonarteritic Anterior Ischemic Optic Neuropathy
-
Aurora, ColoradoRocky Mountain Lions Eye Institute
Aug 23, 2016
Nonarteritic Anterior Ischemic Optic Neuropathy Trial in Tehran (levodopa-carbidopa)
Completed
- Nonarteritic Anterior Ischemic Optic Neuropathy
-
Tehran, Iran, Islamic Republic ofOphthalmic research center
Oct 17, 2008